DRKS00025030
Recruiting
N/A
Prospective non-interventional registry study entitled:Peripartum outcome in vaginally targeted final pelvic births and influencing factors
Zentrum für Frauenheilkunde und Geburtshilfe Universitätsklinikum Frankfurt am Main0 sites1,500 target enrollmentOctober 12, 2021
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- O32.1
- Sponsor
- Zentrum für Frauenheilkunde und Geburtshilfe Universitätsklinikum Frankfurt am Main
- Enrollment
- 1500
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •PATIENT REGISTRATION:
- •\- Mother's date of birth (month/year): (mm/yyyy)
- •\- Date of delivery (month/year): (mm/yyyy)
- •\- Birth book number
- •BASIC DATA:
- •\- Gravidity (number) / parity (number) / abortion/interruption (number) / EUG (extrauterine pregnancy) (Z
- •\- Height (in cm): (number without decimal place)
- •\- Weight before SS (in kg): (number without decimal place)
- •\- BMI (before SS)
- •\- Pelvic diagnosis
Exclusion Criteria
- •missing patient's consent
- •pathology in pregnancy
- •gestational diabetes
- •Uterine malformations
- •Uterine surgery with caval opening
- •Placental abnormalities
- •Pelvic abnormalities
- •Fetal growth retardation
- •Transverse position
- •Fetal malformations
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, Not Recruiting
N/A
The REPLACE Registry for Cholbam® (Cholic Acid)Bile Acid Synthesis DisordersNCT03115086Mirum Pharmaceuticals, Inc.55
Completed
N/A
Patient Characteristics, Treatment Patterns, and Healthcare Resource Utilization of Metastatic Melanoma PatientsMetastatic MelanomaNCT06369428Novartis1,795
Completed
N/A
A prospective, non-interventional study to investigate the effectiveness of a recombinant fusion protein linking coagulation Factor IX with recombinant albumin (rIX-FP) in patients with hemophilia BD67Hereditary factor IX deficiencyDRKS00015079CSL Behring GmbH73
Recruiting
N/A
Prospective registry study to record the diagnosis and treatment of diabetic sensorimotor polyneuropathyG63.2Diabetic polyneuropathyDRKS00017845WÖRWAG Pharma GmbH & Co. KG1,100
Not Yet Recruiting
N/A
A non-interventional, prospective study to evaluate change in physical activity, relationship satisfaction and psychological well-being in patients with rheumatoid arthritis after introduction of the JAK inhibitor filgotinib and also in their partners.M06.8Other specified rheumatoid arthritisDRKS00032128Helios Fachklinik Vogelsang-Gommern, Rheumatologie40